Cargando…

Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles

Autophagy regenerates cellular nutrients, recycles metabolites, and maintains hemostasis through multistep signaling pathways, in conjunction with lysosomal degradation mechanisms. In tumor cells, autophagy has been shown to play a dual role as both tumor suppressor and tumor promoter, leading to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharoonpour, Azar, Simiyari, Dorsa, Yousefzadeh, Ali, Badragheh, Fatemeh, Rahmati, Marveh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196239/
https://www.ncbi.nlm.nih.gov/pubmed/37213283
http://dx.doi.org/10.3389/fonc.2023.1150492
_version_ 1785044304126803968
author Gharoonpour, Azar
Simiyari, Dorsa
Yousefzadeh, Ali
Badragheh, Fatemeh
Rahmati, Marveh
author_facet Gharoonpour, Azar
Simiyari, Dorsa
Yousefzadeh, Ali
Badragheh, Fatemeh
Rahmati, Marveh
author_sort Gharoonpour, Azar
collection PubMed
description Autophagy regenerates cellular nutrients, recycles metabolites, and maintains hemostasis through multistep signaling pathways, in conjunction with lysosomal degradation mechanisms. In tumor cells, autophagy has been shown to play a dual role as both tumor suppressor and tumor promoter, leading to the discovery of new therapeutic strategies for cancer. Therefore, regulation of autophagy is essential during cancer progression. In this regard, the use of nanoparticles (NPs) is a promising technique in the clinic to modulate autophagy pathways. Here, we summarized the importance of breast cancer worldwide, and we discussed its classification, current treatment strategies, and the strengths and weaknesses of available treatments. We have also described the application of NPs and nanocarriers (NCs) in breast cancer treatment and their capability to modulate autophagy. Then the advantages and disadvantaged of NPs in cancer therapy along with future applications will be disscussed. The purpose of this review is to provide up-to-date information on NPs used in breast cancer treatment and their impacts on autophagy pathways for researchers.
format Online
Article
Text
id pubmed-10196239
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101962392023-05-20 Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles Gharoonpour, Azar Simiyari, Dorsa Yousefzadeh, Ali Badragheh, Fatemeh Rahmati, Marveh Front Oncol Oncology Autophagy regenerates cellular nutrients, recycles metabolites, and maintains hemostasis through multistep signaling pathways, in conjunction with lysosomal degradation mechanisms. In tumor cells, autophagy has been shown to play a dual role as both tumor suppressor and tumor promoter, leading to the discovery of new therapeutic strategies for cancer. Therefore, regulation of autophagy is essential during cancer progression. In this regard, the use of nanoparticles (NPs) is a promising technique in the clinic to modulate autophagy pathways. Here, we summarized the importance of breast cancer worldwide, and we discussed its classification, current treatment strategies, and the strengths and weaknesses of available treatments. We have also described the application of NPs and nanocarriers (NCs) in breast cancer treatment and their capability to modulate autophagy. Then the advantages and disadvantaged of NPs in cancer therapy along with future applications will be disscussed. The purpose of this review is to provide up-to-date information on NPs used in breast cancer treatment and their impacts on autophagy pathways for researchers. Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10196239/ /pubmed/37213283 http://dx.doi.org/10.3389/fonc.2023.1150492 Text en Copyright © 2023 Gharoonpour, Simiyari, Yousefzadeh, Badragheh and Rahmati https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gharoonpour, Azar
Simiyari, Dorsa
Yousefzadeh, Ali
Badragheh, Fatemeh
Rahmati, Marveh
Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
title Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
title_full Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
title_fullStr Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
title_full_unstemmed Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
title_short Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
title_sort autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196239/
https://www.ncbi.nlm.nih.gov/pubmed/37213283
http://dx.doi.org/10.3389/fonc.2023.1150492
work_keys_str_mv AT gharoonpourazar autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles
AT simiyaridorsa autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles
AT yousefzadehali autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles
AT badraghehfatemeh autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles
AT rahmatimarveh autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles